TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
RSA Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
417
|
437
|
559 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
249
|
177
|
243 |
| EBITDA |
201
|
184
|
251 |
| Total assets |
454
|
361
|
406 |
| Current assets |
430
|
330
|
366 |
| Current liabilities |
122
|
138
|
175 |
| Equity capital |
300
|
200
|
217 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
66.1%
|
55.4%
|
53.4% |
| Turnover per employee |
208
|
218
|
280 |
| Profit as a percentage of turnover |
59.7%
|
40.5%
|
43.5% |
| Return on assets (ROA) |
54.8%
|
49.0%
|
59.9% |
| Current ratio |
352.5%
|
239.1%
|
209.1% |
| Return on equity (ROE) |
83.0%
|
88.5%
|
112.0% |
| Change turnover |
-21
|
-77
|
-7 |
| Change turnover % |
-5%
|
-15%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.